Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Fluorescence fluctuation spectroscopy: an invaluable microscopy tool for uncovering the biophysical rules for navigating the nuclear landscape.

Priest DG, Solano A, Lou J, Hinde E.

Biochem Soc Trans. 2019 Aug 30;47(4):1117-1129. doi: 10.1042/BST20180604. Epub 2019 Jul 5. Review.

PMID:
31278154
2.

Sub-nucleosomal Genome Structure Reveals Distinct Nucleosome Folding Motifs.

Ohno M, Ando T, Priest DG, Kumar V, Yoshida Y, Taniguchi Y.

Cell. 2019 Jan 24;176(3):520-534.e25. doi: 10.1016/j.cell.2018.12.014. Epub 2019 Jan 17.

PMID:
30661750
3.

Nucleosome-level 3D organization of the genome.

Ohno M, Priest DG, Taniguchi Y.

Biochem Soc Trans. 2018 Jun 19;46(3):491-501. doi: 10.1042/BST20170388. Epub 2018 Apr 6. Review.

PMID:
29626147
4.

Micro-patterned agarose gel devices for single-cell high-throughput microscopy of E. coli cells.

Priest DG, Tanaka N, Tanaka Y, Taniguchi Y.

Sci Rep. 2017 Dec 21;7(1):17750. doi: 10.1038/s41598-017-17544-2.

5.

Promoter activation by CII, a potent transcriptional activator from bacteriophage 186.

Murchland I, Ahlgren-Berg A, Priest DG, Dodd IB, Shearwin KE.

J Biol Chem. 2014 Nov 14;289(46):32094-108. doi: 10.1074/jbc.M114.608026. Epub 2014 Oct 6.

6.

Quantitation of interactions between two DNA loops demonstrates loop domain insulation in E. coli cells.

Priest DG, Kumar S, Yan Y, Dunlap DD, Dodd IB, Shearwin KE.

Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4449-57. doi: 10.1073/pnas.1410764111. Epub 2014 Oct 6.

7.

Quantitation of the DNA tethering effect in long-range DNA looping in vivo and in vitro using the Lac and λ repressors.

Priest DG, Cui L, Kumar S, Dunlap DD, Dodd IB, Shearwin KE.

Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):349-54. doi: 10.1073/pnas.1317817111. Epub 2013 Dec 16.

8.

One-step cloning and chromosomal integration of DNA.

St-Pierre F, Cui L, Priest DG, Endy D, Dodd IB, Shearwin KE.

ACS Synth Biol. 2013 Sep 20;2(9):537-41. doi: 10.1021/sb400021j. Epub 2013 May 20.

PMID:
24050148
9.

Cancer cells activate p53 in response to 10-formyltetrahydrofolate dehydrogenase expression.

Oleinik NV, Krupenko NI, Priest DG, Krupenko SA.

Biochem J. 2005 Nov 1;391(Pt 3):503-11.

10.

The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis.

Hooijberg JH, Peters GJ, Assaraf YG, Kathmann I, Priest DG, Bunni MA, Veerman AJ, Scheffer GL, Kaspers GJ, Jansen G.

Biochem Pharmacol. 2003 Mar 1;65(5):765-71.

PMID:
12628490
12.

Response to 5-fluorouracil chemotherapy is modified by dietary folic acid deficiency in Apc(Min/+) mice.

Tucker JM, Davis C, Kitchens ME, Bunni MA, Priest DG, Spencer HT, Berger FG.

Cancer Lett. 2002 Dec 10;187(1-2):153-62. Erratum in: Cancer Lett. 2003 Dec 8;202(1):119.

PMID:
12359363
14.

Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.

Mauritz R, Peters GJ, Priest DG, Assaraf YG, Drori S, Kathmann I, Noordhuis P, Bunni MA, Rosowsky A, Schornagel JH, Pinedo HM, Jansen G.

Biochem Pharmacol. 2002 Jan 15;63(2):105-15.

PMID:
11841783
15.

Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.

van der Wilt CL, Backus HH, Smid K, Comijn L, Veerman G, Wouters D, Voorn DA, Priest DG, Bunni MA, Mitchell F, Jackman AL, Jansen G, Peters GJ.

Cancer Res. 2001 May 1;61(9):3675-81.

16.

Pharmacokinetic and pharmacodynamic evaluation of the glycinamide ribonucleotide formyltransferase inhibitor AG2034.

McLeod HL, Cassidy J, Powrie RH, Priest DG, Zorbas MA, Synold TW, Shibata S, Spicer D, Bissett D, Pithavala YK, Collier MA, Paradiso LJ, Roberts JD.

Clin Cancer Res. 2000 Jul;6(7):2677-84.

17.

Accumulation of plasma reduced folates after folic acid administration.

Priest DG, Schmitz JC, Bunni MA.

Semin Oncol. 1999 Apr;26(2 Suppl 6):38-41.

PMID:
10598553
18.

Re: Folylpolyglutamyl synthetase gene transfer and glioma antifolate sensitivity in culture and in vivo.

Jansen G, Peters GJ, Pinedo HM, Priest DG, Assaraf YG.

J Natl Cancer Inst. 1999 Dec 1;91(23):2047-50. No abstract available.

PMID:
10580033
19.

Modulation of fluorouracil antitumor activity by folic acid in a murine model system.

Raghunathan K, Priest DG.

Biochem Pharmacol. 1999 Sep 1;58(5):835-9.

PMID:
10449194
20.
21.

A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance.

Jansen G, Mauritz R, Drori S, Sprecher H, Kathmann I, Bunni M, Priest DG, Noordhuis P, Schornagel JH, Pinedo HM, Peters GJ, Assaraf YG.

J Biol Chem. 1998 Nov 13;273(46):30189-98.

22.

Effects of antisense-based folypoly-gamma-glutamate synthetase down-regulation on reduced folates and cellular proliferation in CCRF-CEM cells.

Liu Y, Raghunathan K, Hill C, He Y, Bunni MA, Barredo J, Priest DG.

Biochem Pharmacol. 1998 Jun 15;55(12):2031-7.

PMID:
9714324
23.

Impact of schedule on leucovorin potentiation of fluorouracil antitumor activity in dietary folic acid deplete mice.

Raghunathan K, Schmitz JC, Priest DG.

Biochem Pharmacol. 1997 Apr 25;53(8):1197-202.

PMID:
9175725
24.

Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.

Jansen G, Mauritz RM, Assaraf YG, Sprecher H, Drori S, Kathmann I, Westerhof GR, Priest DG, Bunni M, Pinedo HM, Schornagel JH, Peters GJ.

Adv Enzyme Regul. 1997;37:59-76.

PMID:
9381986
25.

Disposition of leucovorin and its metabolites in dietary folic acid-deplete mice - comparison between tumor, liver, and plasma.

Raghunathan K, Schmitz JC, Priest DG.

Cancer Chemother Pharmacol. 1997;40(2):126-30.

PMID:
9182833
26.

Growth of ovarian-carcinoma cell lines at physiological folate concentration: effect on folate-binding protein expression in vitro and in vivo.

Miotti S, Facheris P, Tomassetti A, Bottero F, Bottini C, Ottone F, Colnaghi MI, Bunni MA, Priest DG, Canevari S.

Int J Cancer. 1995 Nov 3;63(3):395-401.

PMID:
7591238
27.

Rapid quantitative PCR for determination of relative gene expressions in tissue specimens.

Lenz HJ, Hill C, Danenberg KD, Leichman LL, Priest DG, Danenberg PV.

PCR Methods Appl. 1995 Apr;4(5):305-8. No abstract available.

28.

Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM.

Pizzorno G, Moroson BA, Cashmore AR, Russello O, Mayer JR, Galivan J, Bunni MA, Priest DG, Beardsley GP.

Cancer Res. 1995 Feb 1;55(3):566-73.

29.

Evidence for involvement of tyrosine phosphorylation in taxol-induced apoptosis in a human ovarian tumor cell line.

Liu Y, Bhalla K, Hill C, Priest DG.

Biochem Pharmacol. 1994 Sep 15;48(6):1265-72.

PMID:
7945420
30.

Impact of dietary folic acid on reduced folates in mouse plasma and tissues. Relationship to dideazatetrahydrofolate sensitivity.

Schmitz JC, Grindey GB, Schultz RM, Priest DG.

Biochem Pharmacol. 1994 Jul 19;48(2):319-25.

PMID:
8053927
31.

Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia.

Barredo JC, Synold TW, Laver J, Relling MV, Pui CH, Priest DG, Evans WE.

Blood. 1994 Jul 15;84(2):564-9.

32.

Disposition of folic acid and its metabolites: a comparison with leucovorin.

Schmitz JC, Stuart RK, Priest DG.

Clin Pharmacol Ther. 1994 May;55(5):501-8.

PMID:
8181194
33.
34.

Altered transport of folic acid and antifolates through the carrier mediated reduced folate transport system in a human leukemia cell line resistant to (6R) 5,10-dideazatetrahydrofolic acid (DDATHF).

Pavlovic M, Leffert JJ, Russello O, Bunni MA, Beardsley GP, Priest DG, Pizzorno G.

Adv Exp Med Biol. 1993;338:775-8. No abstract available.

PMID:
8304227
35.

Folate metabolites as modulators of antitumor drug activity.

Priest DG, Schmitz JC, Bunni MA.

Adv Exp Med Biol. 1993;338:693-8. Review. No abstract available.

PMID:
8304208
36.

Leucovorin as a prodrug.

Priest DG, Schmitz JC, Walle T.

Adv Exp Med Biol. 1993;339:31-40; discussion 41-2. No abstract available.

PMID:
8178726
37.

Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously.

Priest DG, Schmitz JC, Bunni MA, Stuart RK.

J Natl Cancer Inst. 1991 Dec 18;83(24):1806-12.

PMID:
1744924
38.

A sensitive radioenzymatic assay for (S)-5-formyltetrahydrofolate.

Priest DG, Bunni MA, Romero-Fredes LR, Schmitz JC, Whiteley JM.

Anal Biochem. 1991 Aug 1;196(2):284-9.

PMID:
1776677
39.

Human red blood cell-mediated metabolism of leucovorin [(R,S)5-formyltetrahydrofolate].

Bunni MA, Priest DG.

Arch Biochem Biophys. 1991 May 1;286(2):633-7.

PMID:
1897982
40.

Role of folylpolyglutamates in biochemical modulation of fluoropyrimidines by leucovorin.

Romanini A, Lin JT, Niedzwiecki D, Bunni M, Priest DG, Bertino JR.

Cancer Res. 1991 Feb 1;51(3):789-93.

41.

Inhibition of mammalian thymidylate synthase by 10-formyltetrahydropteroylpolyglutamate.

Balinska M, Rhee M, Whiteley JM, Priest DG, Galivan J.

Arch Biochem Biophys. 1991 Jan;284(1):219-22.

PMID:
1989499
42.

The effect of methotrexate on the folate coenzyme pools in human hepatoma cells in culture.

Galivan J, Rhee M, Priest DG, Bunni M, Freisheim JH, Whiteley JM.

Adv Exp Med Biol. 1991;309A:75-8. No abstract available.

PMID:
1665010
43.

Regulation of drosophila folylpolyglutamates during development.

Duke EJ, Priest DG.

Mol Cell Biochem. 1990 Sep 21;97(2):187-8.

PMID:
1704098
44.

Role of substrate depletion in the inhibition of thymidylate biosynthesis by the dihydrofolate reductase inhibitor trimetrexate in cultured hepatoma cells.

Rhee MS, Balinska M, Bunni M, Priest DG, Maley GF, Maley F, Galivan J.

Cancer Res. 1990 Jul 1;50(13):3979-84.

45.
47.

The effect of methionine on methotrexate metabolism in rat hepatocytes in monolayer culture.

Rhee MS, Johnson TB, Priest DG, Galivan J.

Biochim Biophys Acta. 1989 May 10;1011(2-3):122-8.

PMID:
2565736
48.

Accumulation of tetrahydrofolates in human plasma after leucovorin administration.

Bunni MA, Rembiesa BM, Priest DG, Sahovic E, Stuart R.

Cancer Chemother Pharmacol. 1989;23(6):353-7.

PMID:
2785439
49.
50.

Enhancement of polyacrylamide gel slice dissolution in hydrogen peroxide by cupric sulfate.

Donato H, Doig MT, Priest DG.

J Biochem Biophys Methods. 1988 Apr;15(6):331-5.

PMID:
3379246

Supplemental Content

Loading ...
Support Center